Literature DB >> 11665667

Kinetics of acetyl coenzyme A: arylamine N-acetyltransferase from human cumulus cells.

C C Chang1, Y Y Hsieh, J G Chung, H D Tsai, C H Tsai.   

Abstract

PURPOSE: N-acetyltransferase (NAT) activity is involved in the detoxification of exogenous amines. We aimed to evaluate the kinetics of acetyl coenzyme A (AcCoA): arylamine NAT for human cumulus cells.
METHODS: Thirty infertile women who were undergoing controlled ovarian hyperstimulation (COH) and oocyte retrievals were recruited. Human cumulus cells were obtained during oocyte retrievals. Using 2-aminofluorene (2-AF) and p-aminobenzoic acid (PABA) as substrates, NAT activity and Michaelis-Menten kinetics constants of all samples were determined by using high-pressure liquid chromatography.
RESULTS: There were 6 rapid, 10 intermediate, and 14 slow acetylators. 2-AF-NAT and PABA-NAT activities were 0.97 +/- 0.74 and 0.89 +/- 0.77 nmol/min/mg protein, respectively. Km/Vmax of rapid and slow acetylators for 2-AF were (161 +/- 55)/(15.6 +/- 2.9) and (27.8 +/- 11.4)/(2.6 +/- 0.9), respectively. Km/Vmax of rapid and slow acetylators for PABA were (104 +/- 36)/(13.2 +/- 2.8) versus (20.0 +/- 10)/(2.0 +/- 0.7), respectively. Compared to slow acetylators, the rapid acetylators exhibited higher Km/Vmax values for 2-AF (5.8-/6-fold) and PABA (6-/6.6-fold), respectively.
CONCLUSION: Human cumulus could acetylate arylamine carcinogen (2-AF) and noncarcinogen drug (PABA). Higher percentage of rapid acetylators established in the cumulus during COH. It provides a model for monitoring the effects of pollution or carcinogenesis upon the oocyte during COH and oocyte retrievals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11665667      PMCID: PMC3455732          DOI: 10.1023/a:1016605211332

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  27 in total

Review 1.  N-acetyltransferase.

Authors:  D A Evans
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

2.  Comparison of a single half-dose, long-acting form of gonadotropin-releasing hormone analog (GnRH-a) and a short-acting form of GnRH-a for pituitary suppression in a controlled ovarian hyperstimulation program.

Authors:  Y Hsieh; H Tsai; C Chang; H Lo
Journal:  Fertil Steril       Date:  2000-04       Impact factor: 7.329

Review 3.  The statistical analysis of enzyme kinetic data.

Authors:  W W Cleland
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1967

4.  Biochemical investigation of the basis for the genetic N-acetylation polymorphism in the inbred hamster.

Authors:  D W Hein; W G Kirlin; R J Ferguson; W W Weber
Journal:  J Pharmacol Exp Ther       Date:  1985-08       Impact factor: 4.030

5.  Prostate-specific human N-acetyltransferase 2 (NAT2) expression in the mouse.

Authors:  M A Leff; P N Epstein; M A Doll; A J Fretland; U S Devanaboyina; T D Rustan; D W Hein
Journal:  J Pharmacol Exp Ther       Date:  1999-07       Impact factor: 4.030

6.  Risk of cancer after use of fertility drugs with in-vitro fertilisation.

Authors:  A Venn; L Watson; F Bruinsma; G Giles; D Healy
Journal:  Lancet       Date:  1999-11-06       Impact factor: 79.321

7.  N-acetylation pharmacogenetics: a gene deletion causes absence of arylamine N-acetyltransferase in liver of slow acetylator rabbits.

Authors:  M Blum; D M Grant; A Demierre; U A Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

8.  NAT2 slow acetylator genotype is associated with increased risk of lung cancer among non-smoking Chinese women in Singapore.

Authors:  A Seow; B Zhao; W T Poh; M Teh; P Eng; Y T Wang; W C Tan; E J Lee; H P Lee
Journal:  Carcinogenesis       Date:  1999-09       Impact factor: 4.944

9.  Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer.

Authors:  R A Cartwright; R W Glashan; H J Rogers; R A Ahmad; D Barham-Hall; E Higgins; M A Kahn
Journal:  Lancet       Date:  1982-10-16       Impact factor: 79.321

10.  Acetylation phenotype in colorectal carcinoma.

Authors:  K F Ilett; B M David; P Detchon; W M Castleden; R Kwa
Journal:  Cancer Res       Date:  1987-03-01       Impact factor: 12.701

View more
  2 in total

1.  Leukemia inhibitory factor decreases the arylamine N-acetyltransferase activity in human cumulus granulosa cells.

Authors:  C C Chang; Y Y Hsieh; J G Chung; H D Tsai; C H Tsai
Journal:  J Assist Reprod Genet       Date:  2001-12       Impact factor: 3.412

2.  Microbial and metabolomic mechanisms mediating the effects of dietary inulin and cellulose supplementation on porcine oocyte and uterine development.

Authors:  Zhaoyue Men; Meng Cao; Yuechan Gong; Lun Hua; Ruihao Zhang; Xin Zhu; Lianchao Tang; Xuemei Jiang; Shengyu Xu; Jian Li; Lianqiang Che; Yan Lin; Bin Feng; Zhengfeng Fang; Yong Zhuo
Journal:  J Anim Sci Biotechnol       Date:  2022-01-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.